HOME >> BIOLOGY >> NEWS
Patients undergoing PET/CT may want to pass on that cup of coffee, according to SNMTS study

TORONTO, Canada--Patients who need a positron emission tomography (PET)/computed tomography (CT) procedure to evaluate potential known or suspected malignancies should forgo coffee before the test, according to the results of study released at the Society of Nuclear Medicine's 52nd Annual Meeting June 1822 in Toronto.

"It is advisable for patients to stop caffeine intake for a 24-hour period prior to imaging," said SNM member Medhat M. Osman, M.D., Sc.M., Ph.D., assistant professor in the department of internal medicine's division of nuclear medicine and director of PET at St. Louis University Hospital, St. Louis, Mo. The study, "Correlation Between Myocardial Uptake and Caffeine Intake: Detection With FDG PET/CT," traced the relationship between caffeine intake and myocardial uptake detected by whole-body PET/CT.

PET is a powerful medical imaging modality that noninvasively (nonsurgically) uses special imaging systems and radioactive tracers to produce pictures of the function and metabolism of the cells in the body. CT is an X-ray test that generates a detailed view of the anatomy or structure of organs and tissues in the body. Fused together, PET and CT images can more accurately define a host of diseases processes than can conventional, anatomic-based imaging alone (such as CT and MRI) and can play an important role in cardiac and neurologic imaging.

Most PET scans today are performed with an imaging radiopharmaceutical--most commonly FDG (fluorodeoxyglucose)--that can be tracked by a PET scanner. Where FDG goes in the heart--its uptake into an organ, a tissue, a cell or body fluids--provides a picture of the heart's function. If a person exercises before having a PET/CT scan, more FDG uptake is noted. The researchers found that the same thing happens with caffeine: The heart beats faster when you drink coffee, just as it does when you exercise. Patients who had coffee before their scans had a "significantly higher" myocardial uptake tha
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
20-Jun-2005


Page: 1 2

Related biology news :

1. Patients respond well to first study to test higher doses of an anti-cancer drug
2. Patients to benefit from novel technology revolutionizing high-speed molecular imaging
3. Patients at greater risk if mother has coronary heart disease
4. New bipolar survey: Patients satisfaction influenced
5. Patients own stem cells used to cure incontinence
6. Ultrasound could help couples undergoing IVF
7. Study: Arctic undergoing holistic climate-change response
8. PET/CT use expands: Effectively diagnosing graft infections
9. PET/CT should be first-step test for patients with Crohns disease
10. PET/CT: The best test for women with ovarian cancer
11. PET/CT in Cancer Patient Management examined in Journal of Nuclear Medicine Supplement

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... ... RFID labeling software developer and solutions provider, today reported that the implementation ... accuracy and compliance by 100%, resulting in greater efficiency for global biotechnology ...
(Date:5/28/2020)... Del. (PRWEB) , ... May ... ... Biosciences (DuPont) has announced a new enzyme solution for adjunct liquefaction: AMYLEX® ... alike including the ability to expand into new segments with locally-sourced raw ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective heart ... before becoming adults. The reason: there are no heart valve prosthetics designed ... the Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle Children’s ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a ... Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board ... as work closely with CEO Brian Miller and Sentien’s management team. , ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString Technologies , a ... of industry leaders, clinicians, research scientists, medical professionals and academics from around the ... Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early ... readouts, providing little or no information on the drug’s mechanism of action (MOA). ... of compounds by measuring the activity of molecular pathways. This information can complement ...
Breaking Biology Technology:
Cached News: